At $3.8 we would have only penetrated 1.5% of the target market (based on a 6x revenue valuation ratio, noting TLX is currently @ 8 X based on the last annual report). Whilst I agree we need to compare apples with apples in terms of market cap, we also need to compare the size of the target market, penetration opportunities and the prices and profit margin of the products. On a 6X revenue multiplier we would need to have 6% market share based on the known 7M sufferers in the USA to reach $15 share price.
At $3.8 we would have only penetrated 1.5% of the target market...
-
- There are more pages in this discussion • 19 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add BOT (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
38.0¢ |
Change
0.000(0.00%) |
Mkt cap ! $689.3M | |||
| Open | High | Low | Value | Volume |
| 38.0¢ | 38.5¢ | 37.5¢ | $914.2K | 2.401M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 5 | 82670 | 38.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 38.5¢ | 559520 | 15 |
View Market Depth
| Last trade - 13.14pm 27/09/2024 (20 minute delay) ? |
| BOT (ASX) Chart |